Characterization of an NDM-5-producing hypervirulent Klebsiella pneumoniae sequence type 65 clone from a lung

Jiankang Zhao1, Yulin Zhang1, Yanyan Fan1

  • 1Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases, Beijing, People's Republic of China.

Insights

The first New Delhi Metallo-β-lactamase (NDM)-5 producing hypervirulent Klebsiella pneumoniae strain was identified in a lung transplant recipient. This strain, carrying the blaNDM-5 gene on an IncX3 plasmid, highlights concerns of antimicrobial resistance spread.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • New Delhi Metallo-β-lactamase (NDM)-producing Klebsiella pneumoniae poses a significant global health threat due to its resistance to carbapenems.
  • Hypervirulent Klebsiella pneumoniae strains are increasingly recognized for their ability to cause severe infections.

Observation:

  • The first isolation of NDM-5 producing Klebsiella pneumoniae (strain KP22937) from a lung transplant recipient who succumbed to septic shock.
  • KP22937 was identified as a hypervirulent strain belonging to sequence type 65 and capsule serotype K2, possessing key virulence factors.

Findings:

  • The blaNDM-5 gene was located on an IncX3 plasmid (pNDM22937), which was efficiently transferred to Escherichia coli with minimal fitness cost.
  • The transconjugant E. coli exhibited similar antimicrobial susceptibility and growth characteristics to the parent strain.
  • The IncX3 plasmid carrying blaNDM-5 showed high similarity to previously reported plasmids, suggesting a conserved mechanism for gene dissemination.

Implications:

  • The findings underscore the critical risk of horizontal gene transfer of blaNDM-5 via IncX3 plasmids, particularly involving hypervirulent Klebsiella pneumoniae.
  • Urgent implementation of stricter infection control measures is necessary to curb the spread of this emerging multidrug-resistant clone in healthcare settings.